Suppr超能文献

血浆中吡罗昔康和萘普生游离浓度的测定。平衡透析中实验条件的影响。

Determination of free concentration of piroxicam and naproxen in plasma. The influence of experimental conditions in equilibrium dialysis.

作者信息

Hundal O, Rugstad H E

机构信息

Dept of Clinical Pharmacology, National Hospital, Oslo, Norway.

出版信息

Fundam Clin Pharmacol. 1991;5(4):275-83. doi: 10.1111/j.1472-8206.1991.tb00722.x.

Abstract

An equilibrium dialysis method was established in order to investigate possible relationships between free drug concentrations of piroxicam and naproxen and clinical events. Therefore the influence of variations in pH, phosphate concentration and sodium azide concentration of the dialysis buffer on the free concentrations of piroxicam and naproxen was investigated. Piroxicam was found to have a pH-dependent protein binding. Therefore a good control of pH during the dialysis process is necessary. This has been achieved by increasing the buffer capacity of the dialysis buffer, by adding an antibacterial agent to the dialysis buffer and by cleansing the dialysis cells with 70% ethanol before use to prevent bacterial growth. Addition of 0.03% sodium azide as an antibacterial agent and the use of a 0.09 mol/l phosphate buffer gave good pH control. A method to correct for deviations of pH in measurements of free concentrations of piroxicam by a simple mathematical correction has been found. As naproxen was found to have a protein binding independent of pH, a pH-correction is not necessary for this drug. Standardized conditions in determination of protein binding of drugs by equilibrium dialysis are important, as composition of the dialysis buffer and pH of plasma compartment at equilibrium may influence the free concentration measurements. Comparisons of data from experiments using different methods are therefore difficult; the importance of pH-control is stressed. With the methods used in the present investigation, equilibrium dialysis in connection with HPLC, the coefficients of variation for piroxicam and naproxen free concentrations are 5.5% and 7.4%, respectively.

摘要

为了研究吡罗昔康和萘普生的游离药物浓度与临床事件之间可能存在的关系,建立了一种平衡透析方法。因此,研究了透析缓冲液的pH值、磷酸盐浓度和叠氮化钠浓度的变化对吡罗昔康和萘普生游离浓度的影响。发现吡罗昔康具有pH依赖性蛋白结合。因此,在透析过程中对pH值进行良好控制是必要的。这已通过增加透析缓冲液的缓冲容量、向透析缓冲液中添加抗菌剂以及在使用前用70%乙醇清洗透析池以防止细菌生长来实现。添加0.03%叠氮化钠作为抗菌剂并使用0.09 mol/l磷酸盐缓冲液可实现良好的pH控制。已找到一种通过简单数学校正来校正吡罗昔康游离浓度测量中pH偏差的方法。由于发现萘普生的蛋白结合与pH无关,因此该药物无需进行pH校正。通过平衡透析测定药物蛋白结合的标准化条件很重要,因为透析缓冲液的组成和平衡时血浆隔室的pH值可能会影响游离浓度测量。因此,比较使用不同方法的实验数据很困难;强调了pH控制的重要性。使用本研究中采用的方法,即结合高效液相色谱的平衡透析法,吡罗昔康和萘普生游离浓度的变异系数分别为5.5%和7.4%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验